CD8A and neoplasm: Third, our findings demonstrate that synthetically linking a NeoAg-specific or universal CD4+ T cell epitope with a NeoAg-specific CD8+ T cell epitope in a single vaccine construct allows for optimal stimulation of the endogenous immune system in a tumor-bearing host, effectively mediating complete rejection of a large primary tumor burden and metastases.